Congenital Cardiac Anesthesia Society
A Section of the the Society for Pediatric Anesthesia

Congenital Cardiac Anesthesia Society

  • Member Login
  • Forgot Password?
  • Join
  • Home
  • About
    • Mission Statement
    • Bylaws
    • Board of Directors
    • History
    • Past Presidents
    • Charter Members
    • CCAS Lifetime Achievement Award
    • Mailing List Rental
    • Contact Us
  • Partners
    • SPA
    • SPPM
    • PALC
    • PCICS
    • AmSECT
    • SMACT
    • CHA
    • CCAN
  • Committees
    • CCAS Committees
      • Pediatric Cardiac Anesthesiology Program Director’s Group (PCAPD) Committee
      • Communications Committee
      • CCAS-STS Database Committee
      • Education Committee
      • Global Health Committee
      • Membership Committee
      • Quality and Safety Committee
      • Research Committee
    • CCAS Special Interest Groups
      • Adult Congenital Heart Disease Special Interest Group (SIG)
      • ERAS Special Interest Group (SIG)
      • Hemostasis Special Interest Group (SIG)
      • Latin America Special Interest Group (SIG)
      • Pulmonary Hypertension Special Interest Group (SIG)
      • Trainee Special Interest Group (SIG)
  • Membership
    • Benefits of Membership
    • CCAS Member App
    • Membership Categories
    • Join CCAS
      • Online Application
      • Printable Application
    • Renew Your Dues
    • Sponsor a Member
    • Get Involved
  • Meetings
    • Upcoming Meetings
    • Past Meetings
    • Other Meetings
    • Exhibit Information
  • Education
    • CCAS Virtual Visiting Professor Program
    • CCAS Webinar Series
      • CCAS Webinar Series – Recordings
    • CCAS COVID 19 Webinar
    • ACHD-SIG Anesthesia Rounds
    • Lecture Series
    • Echo Tutorial
    • Archived Questions
    • Poll of the Month Archives
    • Review Articles
      • CCAS-CHiP Network Journal Watch Collaboration
      • SCVA Articles
    • Journals of Interest
    • Books of Interest
    • Educational Links
  • Resources
    • CCAS Position Statements
    • CCAS Committee Resources
    • CCAS Special Interest Group (SIG) Resources
    • CCAS Cognitive Aids
    • Newsletters
    • Research Resources
    • Mission Trips
    • Societies
    • Job Opportunities
  • Research
    • Research Committee
    • CCAS 2025 Meeting Scholarship for Students and Residents
    • Research Network & Collaborative Opportunities
    • Research Resources
    • Dolly D. Hansen, MD Research Award
    • Podcast Series for Aspiring CCAS Researchers
    • Highlight on a CCAS Researcher
    • Call for Surveys
    • STS-CCAS Database
    • Donate to the Dolly Hansen Fund
    • Grant Opportunities
  • Trainees
    • Introduction to Pediatric Cardiac Anesthesiology
    • Trainee Lecture Series
    • Advanced Training
    • Pediatric Cardiac Anesthesiology Fellowship Common Goals and Objectives
    • Frequently Asked Questions
    • Pediatric Cardiac Anesthesia Education Resources
    • Coaching/Mentoring Initiative
  • Patients
    • FAQs for Cardiac Anesthesia
    • FAQs for Cardiac Anesthesia – Spanish
    • SmartTots FAQs for Parents
    • Useful Resources for Parents

QOW 338

Author: Sana Ullah, MB ChB, FRCA - Children’s Medical Center, Dallas


An 11-month-old male infant with severe pulmonary valve stenosis and estimated peak systolic gradient of 110 mmHg presents for balloon pulmonary valvuloplasty. Immediately following balloon valvuloplasty, the vital signs are as follows: heart rate 165 beats per minute, blood pressure 53/21, and oxygen saturation 60%. Which of the following measures is the MOST APPROPRIATE next step in his management?

Correct! Wrong!

Question of the Week 338
This patient has developed a rare but serious complication colloquially known as a “suicide right ventricle” or dynamic right ventricular infundibular obstruction following balloon pulmonary valvuloplasty. Severe pulmonary valve stenosis can result in significant right ventricular hypertrophy and in particular right infundibular hypertrophy. An acute relief of the valvar gradient can suddenly unmask a previously unknown infundibular gradient leading to dynamic right ventricular outflow tract obstruction. The pathophysiology is similar to left ventricular outflow tract obstruction in the setting of hypertrophic cardiomyopathy. The mainstay of treatment is to reduce the heart rate and contractility with a beta blocker such as esmolol, labetalol, or propranolol. The decrease in contractility allows for improved ventricular filling during diastole. Beta blockade with oral propranolol may be necessary for a period of time after balloon valvuloplasty to allow for ventricular remodeling. In this case, esmolol is the appropriate treatment due to the fast onset of action given severe oxygen desaturation and hypotension.


In this case, an epinephrine bolus would not be helpful because the oxygen desaturation and hypotension are due to right ventricular infundibular obstruction rather than ventricular dysfunction. An epinephrine bolus would increase contractility and likely worsen the signs of infundibular obstruction.


Although this patient likely has right ventricular diastolic dysfunction, a milrinone bolus would acutely produce systemic vasodilation and thereby worsen hypotension.


Inhaled nitric oxide would not be indicated in the treatment of right ventricular infundibular obstruction as it would reduce pulmonary arterial pressure rather than relieve infundibular obstruction.


References:


1) Khambatta H, Velado M, Gaffney J, Schechter W, Casta A. Management of right ventricular tract reactivity following pulmonary valve dilation after general anesthesia: experience of a medical mission. Pediatric Anesthesia. 2006; 16(10): 1087-1089.


2) Ben-Shachar G, Cohen M, Sivakoff M, Portman M, Riemenschneider T, Van Heeckeren D. Development of infundibular obstruction after percutaneous pulmonary balloon valvuloplasty. J Am Coll Cardiol. 1985; 5(3): 754-756.


3) Tharpar MK, Rao PS. Significance of infundibular obstruction following balloon valvuloplasty for valvar pulmonic stenosis. Am Heart J. 1989; 118: 99-103.


Poll of the Month

May 2025
At your institution, do you routinely send a TEG/ROTEM during the rewarming phase of cardiopulmonary bypass?
View Results
Total Answers 64
Total Votes 64

Upcoming Meeting Information


CCAS 2026 Annual Meeting

March 12, 2026
Sheraton Denver Downtown
Denver, CO

 

 

 

 

Join CCAS
Renew
Donate
Get Involved
Upcoming
Job Postings
  • Member Login
  • Forgot Password?
2209 Dickens Road, Richmond, VA 23230 • 804-282-9780 • [email protected]
Copyright © 2025 The Congenital Cardiac Anesthesia Society | View Privacy Policy